Recent studies have attempted to measure differences in lifestyle quality across the world. This paper contributes to this strand of literature by extending the indicator introduced in Milevsky (2020), i.e., “longevity-risk-adjusted global age” (LRaG age), to deal with the new short-term mortality fluctuation data series freely available from the Human Mortality Database. The new weekly data on mortality allow measuring weekly biological age. The weekly differences between biological and chronological ages across countries were used to assess country resilience to the COVID-19 pandemic in terms of excess mortality and health expenditure. Countries with a biological age lower than the chronological age had a lower excess mortality in 2020–2021 and a lower health expenditure, thus indicating some resilience to the shock of COVID-19.

Short-Term Mortality Fluctuations and Longevity Risk-Adjusted Age: Learning the Resilience of a Country to a Health Shock / Polinesi, G.; Recchioni, M. C.; Rimondi, A.; Sysoev, A.. - In: COMPUTATION. - ISSN 2079-3197. - 10:4(2022), p. 47. [10.3390/computation10040047]

Short-Term Mortality Fluctuations and Longevity Risk-Adjusted Age: Learning the Resilience of a Country to a Health Shock

Polinesi G.;Recchioni M. C.;Rimondi A.;Sysoev A.
2022-01-01

Abstract

Recent studies have attempted to measure differences in lifestyle quality across the world. This paper contributes to this strand of literature by extending the indicator introduced in Milevsky (2020), i.e., “longevity-risk-adjusted global age” (LRaG age), to deal with the new short-term mortality fluctuation data series freely available from the Human Mortality Database. The new weekly data on mortality allow measuring weekly biological age. The weekly differences between biological and chronological ages across countries were used to assess country resilience to the COVID-19 pandemic in terms of excess mortality and health expenditure. Countries with a biological age lower than the chronological age had a lower excess mortality in 2020–2021 and a lower health expenditure, thus indicating some resilience to the shock of COVID-19.
2022
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/299516
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact